CLOFARABINE, MELPHALAN AND THIOTEPA REDUCED-INTENSITY CONDITIONING CHEMOTHERAPY ALONG WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED GRAFT VERSUS HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANT

被引：0
|
作者：
Verduzco, Alejandro Del Rio [1 ]
Go, Aileen [1 ]
Kodali, Murali [1 ]
Ulrickson, Matthew [1 ]
De Padova, Nicolas [1 ]
Smith, Eric [1 ]
Komerdelj, Ivan [1 ]
Heers, Hayley [1 ]
Brookes, Jennifer [1 ]
Pebler, Haley [1 ]
Yasuda, Rachael [1 ]
Nath, Rajneesh [1 ]
机构：
[1] Banner MD Anderson Canc Ctr, Gilbert, AZ USA
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P202
引用
收藏
页码：283 / 284
页数：2
相关论文
共 50 条
  • [21] Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
    Ganetsky, Alex
    Shah, Arpita
    Miano, Todd A.
    Hwang, Wei-Ting
    He, Jiwei
    Frey, Noelle V.
    Porter, David L.
    Reshef, Ran
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S369 - S369
  • [22] Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide As Graft Versus-Host Disease Prophylaxis in Pediatric Hematologic Malignancies
    Lopez-Hernandez, Gerardo
    Lopez-Santiago, Norma
    Olaya-Vargas, Alberto
    Perez-Garcia, Martin
    Nideshda Ramirez-Uribe, Rosa Maria
    del Pilar Salazar-Rosales, Haydee
    Del Campo-Martinez, Angeles
    Alejandra Xiqui-Jardines, Laura
    BLOOD, 2018, 132
  • [23] POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN HLA-IDENTICAL SIBLING HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Bailen, Rebeca
    Kwon, Mi
    Pascual Cascon, Maria Jesus
    Balsalobre, Pascual
    Diaz Aizpun, Carlota
    Benitez Hidalgo, Olga
    Serrano, David
    Anguita, Javier
    Buno, Ismael
    Dorado, Nieves
    Solan, Laura
    Luis Diez-Martin, Jose
    BONE MARROW TRANSPLANTATION, 2018, 53 : 437 - 438
  • [24] Post-Transplant Cyclophosphamide versus Methotrexate-Based Regimen as Graft Versus Host Disease Prophylaxis after Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Leukemia
    El Shamy, Alaa
    Elmohsen, Essam Abd
    Denewer, Mai
    Mabed, Mohamed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S174 - S174
  • [25] Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant
    Nikolousis, E.
    Robinson, S.
    Nagra, S.
    Brookes, C.
    Kinsella, F.
    Tauro, S.
    Jeffries, S.
    Griffiths, M.
    Mahendra, P.
    Cook, M.
    Paneesha, S.
    Lovell, R.
    Kishore, B.
    Chaganti, S.
    Malladi, R.
    Raghavan, M.
    Moss, P.
    Milligan, D.
    Craddock, C.
    LEUKEMIA RESEARCH, 2013, 37 (05) : 561 - 565
  • [26] Easix Application in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Prophylaxis
    Escribano Serrat, Silvia
    Charry, Paola
    Gerardo Rodriguez-Lobato, Luis
    Belen Moreno-Castano, Ana
    Suarez-Lledo, Maria
    Martinez-Cibrian, Nuria
    Teresa Solano, Maria
    Arcarons, Jordi
    Nomdedeu, Meritxell
    Cid, Joan
    Lozano, Miquel
    Pedraza, Alexandra
    Rosinol, Laura
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    Palomo, Marta
    Fernandez-Aviles, Francesc
    Martinez Munoz, Maria Carmen
    Diaz-Ricart, Maribel
    Carreras, Enric
    Rovira, Montserrat
    Queralt Salas, Maria
    BLOOD, 2022, 140 : 7616 - 7618
  • [27] Graft-Versus-Host Disease Prophylaxis with Post-Transplant Cyclophosphamide Better Preserves Regulatory T Cell
    Koh, Jeong Suk
    Heo, Buyeon
    Lee, Seul Bi
    Choi, Su-Young
    Pham, Thi Thuy Duong
    Lee, Sang-Woo
    Park, Jung-Hyun
    Jang, Yunseon
    Seo, Wonhyoung
    Lee, Myung-Won
    Jo, Deog-Yeon
    Kwon, Jaeyul
    Song, Ik Chan
    BLOOD, 2024, 144 : 7371 - 7371
  • [28] Similar Cardiac Toxicity Following Allogeneic Hematopoietic Cell Transplant (alloHCT) with Post-Transplant Cyclophosphamide Versus Calcineurin Inhibitor-Based Graft-Versus-Host Disease Prophylaxis
    Vazquez-Martinez, Mariola A.
    Caprice, Teresa
    Amisha, Fnu
    Almaraz, Andrew
    Kim, Jongphil
    Cao, Biwei
    Alomar, Mohammed E.
    Khimani, Farhad
    Mishra, Asmita
    Nieder, Michael
    Lazaryan, Aleksandr
    Ochoa-Bayona, Jose L.
    Nishihori, Taiga
    Mirza, Sayeef
    Faramand, Rawan
    Perez, Lia
    Anasetti, Claudio
    Pidala, Joseph A.
    Bejanyan, Nelli
    Elmariah, Hany
    BLOOD, 2024, 144 : 4871 - 4872
  • [29] Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant
    Ruggeri, Annalisa
    Sun, Yuqian
    Labopin, Myriam
    Bacigalupo, Andrea
    Lorentino, Francesca
    Arcese, William
    Santarone, Stella
    Gulbas, Zafer
    Blaise, Didier
    Messina, Giuseppe
    Ghavamzadeh, Ardeshi
    Malard, Florent
    Bruno, Benedetto
    Diez-Martin, Jose Luis
    Koc, Yener
    Ciceri, Fabio
    Mohty, Mohamad
    Nagler, Arnon
    HAEMATOLOGICA, 2017, 102 (02) : 401 - 410
  • [30] Predictors of Graft-Versus-Host Disease with Post-Transplant Cyclophosphamide
    Saliba, Rima M.
    Aljawai, Yosra M.
    Alousi, Amin M.
    Oran, Betul
    Popat, Uday
    Champlin, Richard E.
    Shpall, Elizabeth J.
    BLOOD, 2024, 144 : 4890 - 4891
12345